Drug News: December 2012/January 2013Divigel: new topical gel for menopausal symptoms; Esbriet for idiopathic pulmonary fibrosis; other new products; new indications; new dosage guidelines; and new generics. Adverse Reactions: Calcitonin and cancer riskHealth Canada reviewing European recommendations that restrict use of calcitonin because of evidence suggesting an increased risk of cancer. Fasting not needed Cracking the complexity of chronic pelvic pain The causes of CPP can be challenging to diagnose and treat, but family physicians are in an ideal position to help women struggling with this pain MY FINE WHINE: The sticky wicket of female physicians’ marital finances Sulfonylureas: higher cardiovascular risk than metformin in type 2 diabetes Initiating treatment with a sulfonylurea rather than metformin in patients with type 2 diabetes is associated with an increased hazard of CVD events or death, new study finds. What your patients are reading - week of Nov. 12, 2012 HRT has heart benefits in younger menopausal women But Danish study’s conclusions are ‘misleading,’ says Canadian cardiologist Calcium prevents parathyroid problems in women Survey reveals gaps in hypoglycemia management in Canadian diabetes patients First Previous 152 153 154 155 156 Next Last
